I'd argue that is
Notable
if it hasn't already been picked up
They don't quite say that in the complaint. They say it's a risk that should be investigated.
The complaint is well done and may lead to a hold in Europe. The section on antibody-dependent enhancement is good - that's the biggest concern I have with the vaccine (this or any other anti-COVID vaccine)